BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 7780978)

  • 1. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q; Moan J; Ma LW; Nesland JM
    Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat.
    Desroches MC; Bautista-Sanchez A; Lamotte C; Labeque B; Auchère D; Farinotti R; Maillard P; Grierson DS; Prognon P; Kasselouri A
    J Photochem Photobiol B; 2006 Oct; 85(1):56-64. PubMed ID: 16765603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
    Hornung R; Walt H; Crompton NE; Keefe KA; Jentsch B; Perewusnyk G; Haller U; Köchli OR
    Photochem Photobiol; 1998 Oct; 68(4):569-74. PubMed ID: 9796440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic treatment as a novel approach in the therapy of arthritic joints.
    Hansch A; Frey O; Gajda M; Susanna G; Boettcher J; Bräuer R; Kaiser WA
    Lasers Surg Med; 2008 Apr; 40(4):265-72. PubMed ID: 18412224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
    Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
    J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
    Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
    Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
    Peng Q; Moan J
    Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats.
    Olivier D; Bourré L; El-Sabbagh E; Loussouarn D; Simonneaux G; Valette F; Patrice T
    Surg Neurol; 2007 Sep; 68(3):255-63; discussion 263. PubMed ID: 17544487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z; Gibson SL; Foster TH; Hilf R
    Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer.
    Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS
    Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A; Kessel D; Gomer CJ
    Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M; Pimstone N
    Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
    Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
    Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
    Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
    Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model.
    Hornung R; Fehr MK; Monti-Frayne J; Krasieva TB; Tromberg BJ; Berns MW; Tadir Y
    Photochem Photobiol; 1999 Oct; 70(4):624-9. PubMed ID: 10546556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.